Literature DB >> 6608424

Anti-perinuclear and rheumatoid factor in different forms of autoimmune thyroid disease.

W A Scherbaum, P Y Youinou, P Le Goff, G F Bottazzo.   

Abstract

Anti-perinuclear factors (APF), IgM-, IgG- and IgA-rheumatoid factors have been detected in six, five, one and three out of 20 patients with primary myxoedema, respectively. We were unable to find APF in 22 patients with Hashimoto's thyroiditis nor in 20 patients with Graves' thyrotoxicosis. APF appears to be a marker for non-organ specific autoimmune diseases.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6608424      PMCID： PMC1535913     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


  8 in total

1.  A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR.

Authors:  R L NIENHUIS; E MANDEMA
Journal:  Ann Rheum Dis       Date:  1964-07       Impact factor: 19.103

2.  IMMUNOFLUORESCENT TEST FOR RHEUMATOID FACTOR IN SERUM.

Authors:  G D JOHNSON; E J HOLBOROW
Journal:  Lancet       Date:  1963-11-30       Impact factor: 79.321

3.  Autoantibodies in rheumatic diseases.

Authors:  W Scherbaum
Journal:  Lancet       Date:  1980-01-19       Impact factor: 79.321

4.  [Relation between antiperinuclear factors, anti-keratin antibodies and the agglutinating and non-agglutinating rheumatoid factor in chronic polyarthritis].

Authors:  P Youinou; P Le Goff; P Miossec; M P Moineau; C Ferec
Journal:  Z Rheumatol       Date:  1983 Jan-Feb       Impact factor: 1.372

5.  Evidence for an association between rheumatoid arthritis and autoimmune endocrine disease.

Authors:  D J Thomas; A Young; A N Gorsuch; G F Bottazzo; A G Cudworth
Journal:  Ann Rheum Dis       Date:  1983-06       Impact factor: 19.103

6.  Antiperinuclear factor and keratin antibodies in rheumatoid arthritis.

Authors:  G D Johnson; A Carvalho; E J Holborow; D H Goddard; G Russell
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

7.  [Rheumatoid factors in Basedow's disease].

Authors:  W A Scherbaum; K O Rosenau; F J Seif
Journal:  Z Rheumatol       Date:  1978 Nov-Dec       Impact factor: 1.372

8.  The antiperinuclear factor. 1. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis.

Authors:  I R Sondag-Tschroots; C Aaij; J W Smit; T E Feltkamp
Journal:  Ann Rheum Dis       Date:  1979-06       Impact factor: 19.103
  8 in total
  6 in total

1.  The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies.

Authors:  M Sebbag; M Simon; C Vincent; C Masson-Bessière; E Girbal; J J Durieux; G Serre
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

2.  Increased risk of thyroid autoimmunity in rheumatoid arthritis.

Authors:  Ulla Feldt-Rasmussen
Journal:  Endocrine       Date:  2015-06-23       Impact factor: 3.633

3.  Rheumatic manifestations of euthyroid, anti-thyroid antibody-positive patients.

Authors:  Clement E Tagoe; Anna Zezon; Saakshi Khattri; Patricia Castellanos
Journal:  Rheumatol Int       Date:  2013-01-05       Impact factor: 2.631

4.  Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin.

Authors:  R M Hoet; A M Boerbooms; M Arends; D J Ruiter; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

5.  Antikeratin antibodies in serum and synovial fluid show specificity for rheumatoid arthritis in a study of connective tissue diseases.

Authors:  P Youinou; P Le Goff; C B Colaco; J Thivolet; D Tater; J Viac; M Shipley
Journal:  Ann Rheum Dis       Date:  1985-07       Impact factor: 19.103

6.  Organ-specific autoantibodies in non-organ-specific autoimmune diseases with special reference to rheumatoid arthritis.

Authors:  P Youinou; W Mangold; J Jouquan; H Swirsky; P Le Goff; W A Scherbaum
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.